Small Intestine Cancer
📧 Sign up to get email alerts when something new happens for Small Intestine Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: RCT of Mobile Apps & FitBit v. Usual Care [NA]
An ongoing randomized trial compares a mobile apps plus FitBit intervention to usual care in patients with pancreatic, gastric, liver, colon…
-
CLINICAL_TRIALS research · 2025-10-27Clinical Trial Update: Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)
A completed Medtronic clinical trial prospectively collecting PillCam SB3 videos and raw data files for future development.
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers [Phase 1]
Phase 1 clinical trial update evaluating the NALIRIFOX regimen (nal-IRI plus 5-FU/LV plus oxaliplatin) as first-line therapy for advanced sm…
-
CLINICAL_TRIALS research · 2025-01-06Clinical Trial Update: Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) [NA]
The LIVELONG trial from University of California, Davis is an ongoing study evaluating locally ablative therapy for oligoprogressive gastroi…
-
CLINICAL_TRIALS research · 2015-08-27Clinical Trial Update: Enteroscopy for Early Diagnosis of Tumors in Celiac Disease [NA]
Clinical trial update describes an enteroscopy study for early diagnosis of tumors in people with celiac disease. The trial status is curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-08-08Clinical Trial Update: Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma [Phase 2]
Phase II clinical trial evaluating brostallicin or doxorubicin as first-line therapy for relapsed, refractory, or metastatic soft tissue sar…
-
CLINICAL_TRIALS research · 2013-12-04Clinical Trial Update: Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for pediatric metastatic rhabdomyosarcoma and other malignant mesenchymal tumors; …
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma [Phase 2]
This is a Phase 2 trial update evaluating high-dose chemotherapy with peripheral blood stem cell transplant for intestinal T-cell lymphoma.
-
CLINICAL_TRIALS research · 2013-08-26Clinical Trial Update: Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma [Phase 1]
Phase 1 trial of alemtuzumab combined with chemotherapy for peripheral T-cell lymphoma (stages I–IV); current status is unknown.